AZD2171 (cediranib)

cediranib · AstraZeneca

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AZD2171 (cediranib), covering 2013-09-26 to 2015-11-09. Get the full timeline:

Most recent: Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 2]